XML 42 R24.htm IDEA: XBRL DOCUMENT v3.24.1
EARNINGS (LOSS) PER SHARE
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE
 16. EARNINGS (LOSS) PER SHARE
The reconciliations of the net income (loss) and the weighted average number of shares used in the computations of basic and diluted earnings (loss) per share attributable to Jushi shareholders are as follows:
Year Ended December 31,
202320222021
Numerator:
Net income (loss) and comprehensive income (loss) attributable to Jushi shareholders
$(65,102)$(202,324)$20,251 
Dilutive effect of net income from derivative warrants— (91,887)(104,594)
Net income (loss) and comprehensive loss attributable to Jushi shareholders - diluted
$(65,102)$(294,211)$(84,343)
Denominator:
Weighted-average shares of common stock - basic194,770,212 190,021,550 170,292,035 
Dilutive effect of derivative warrants— 14,213,882 31,318,216 
Weighted-average shares of common stock - diluted194,770,212 204,235,432 201,610,251 
Earnings (loss) per share - basic
$(0.33)$(1.06)$0.12 
Earnings (loss) per share - diluted
$(0.33)$(1.44)$(0.42)
In August 2021, all the 149,000 previously issued and outstanding Super Voting Shares and all the 4,000,000 previously outstanding Multiple Voting Shares were converted into SVS in accordance with their terms as described in Jushi Holdings Inc.’s Articles of Incorporation. Refer to Note 14 - Equity. The number of basic and diluted weighted-average shares outstanding for 2021 assumes the conversion of the Multi Voting Share and Super Voting Shares into SVS as of the beginning of the year. Other than voting rights, the Multi Voting Shares and Super Voting Shares had the same rights as the SVS and therefore all these shares are treated as the same class of common stock for purposes of the earnings (loss) per share calculations.
The following table summarizes equity instruments that may, in the future, have a dilutive effect on earnings (loss) per share, but were excluded from consideration in the computation of diluted net earnings (loss) per share for the years ended December 31, 2023, 2022 and 2021 because the impact of including them would have been anti-dilutive:
As of December 31,
202320222021
Stock options28,783,139 30,752,259 20,429,120 
Warrants (derivative liabilities and equity)
85,575,031 30,673,635 29,156,048 
Unvested restricted stock awards368,711 1,156,319 2,859,151 
Convertible promissory notes — — 910,000 
114,726,881 62,582,213 53,354,319